Acer Therapeutics Inc reports results for the quarter ended in June - Earnings Summary

Acer Therapeutics

14/08/2023 22:41

* Acer Therapeutics Inc  ACER.OQ  reported a quarterly
adjusted
loss of 33 cents​​ per share for the quarter ended in June. The
mean expectation of two analysts for the quarter was for a loss
of 25 cents per share.
    * Reported revenue was zero​; analysts expected $300.00
thousand. 
    * Acer Therapeutics Inc's reported EPS for the quarter was a
loss
of 33 cents​.
    * The mean earnings estimate of analysts had risen by
about 10.5%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Acer Therapeutics Inc shares had fallen by 22.0% this
quarter and lost 71.3% so far this year.
    * The company reported a quarterly loss of $8.09 million.
    * Wall Street's median 12-month price target for Acer
Therapeutics
Inc is $11.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
August 14 at 09:41 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2023      -0.25          -0.33          Missed
 Mar. 31 2023      -0.28          -0.77          Missed
 Dec. 31 2022      -0.37          -0.54          Missed
 Sep. 30 2022      -0.68          -0.31          Beat